You are here: Welcome to the MPKB » Welcome to the MPKB » Science behind Pathogenesis » Microbes in the human body » Effects of bacteria and viruses on their human host
Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision		Previous revision
Next revisionBoth sides next revision
home:pathogenesis:microbiota:interaction [03.16.2020] – [Viruses] sallieqhome:pathogenesis:microbiota:interaction [03.28.2020] – [Viruses] sallieq
Line 30: Line 30:
  
 [[https://www.youtube.com/watch?v=1vZDVbqRhyM|discussion of coronavirus and ACE inhibitors]] [[https://www.youtube.com/watch?v=1vZDVbqRhyM|discussion of coronavirus and ACE inhibitors]]
 +
 +[[https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30183-5/fulltext|Clinical features of Covid-19 reported from Wuhan Feb2020]]
 +
 +[[https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30132-8/fulltext|3 Antiviral and anti-inflammatory treatments compared]]
 +
 +[[http://www.koreabiomed.com/news/articleView.html?idxno=7428|Treatment guidelines for coronavirus (Korea 2020)]]
 +
 +[[http://www.koreabiomed.com/news/articleView.html?idxno=7718|Fewer new cases 20/3/2020 (Korea) ]]
 +
 +current evidence(({{pubmed>long:    32096567}}))
 +
 +breakthrough(({{pubmed>long:    32074550}}))
 +
 +chloroquine (({{pubmed>long:    32147496}}))
 +
 + neuroinvasive potential(({{pubmed>long:    32104915}}))
 +
 +Unique epidemiological and clinical features(({{pubmed>long:    32134116}}))
 +
 +What we know so far(({{pubmed>long:    32139372}}))
 +
 +Presumed Asymptomatic Carrier Transmission(({{pubmed>long:    32083643}}))
 +
 +Discovering drugs(({{pubmed>long:    32147628}}))
 +
 +
 +[[https://www.mediterranee-infection.com/wp-content/uploads/2020/03/Hydroxychloroquine_final_DOI_IJAA.pdf|small sample size survey shows hydroxychloroquine treatment is significantly associated with viral load reduction in COVID-19 patients, effect is reinforced by azithromycin.]]
 +
 +February 2020 The multicenter collaboration group of Department of Science and Technology of Guangdong Province and Health Commission of Guangdong Province for chloroquine in the treatment of novel coronavirus pneumonia developed this expert consensus after extensive discussion. It recommended chloroquine phosphate tablet, 500mg twice per day for 10 days for patients diagnosed as mild, moderate and severe cases of novel coronavirus pneumonia and without contraindications to chloroquine. (({{pubmed>long:32075365}})) 
 +
 ==== Bacteria ==== ==== Bacteria ====
  
home/pathogenesis/microbiota/interaction.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.